Literature DB >> 23622616

Living donor liver transplantation for alveolar echinococcus is a difficult procedure.

S Hatipoglu1, B Bulbuloglu, T Piskin, C Kayaalp, S Yilmaz.   

Abstract

Surgical resection is the best treatment for early stage alveolar echinococcosis of the liver. In the stages that are not appropriate for resection and when the case develops complications, a liver transplant can be a lifesaver. The liver transplants of alveolar echinococcosis are technically difficult because of prior operation, interventional radiological procedures, and large mass. Despite such difficulty, living donor liver transplantation can save one's life.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622616     DOI: 10.1016/j.transproceed.2013.02.084

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  11 in total

1.  Application of 3D reconstruction for surgical treatment of hepatic alveolar echinococcosis.

Authors:  Yi-Biao He; Lei Bai; Tuerganaili Aji; Yi Jiang; Jin-Ming Zhao; Jin-Hui Zhang; Ying-Mei Shao; Wen-Ya Liu; Hao Wen
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Application of a Three-Dimensional Reconstruction Technique in Liver Autotransplantation for End-Stage Hepatic Alveolar Echinococcosis.

Authors:  Yi-Biao He; Lei Bai; Yi Jiang; Xue-Wen Ji; Qin-Wen Tai; Jin-Ming Zhao; Jin-Hui Zhang; Wen-Ya Liu; Hao Wen
Journal:  J Gastrointest Surg       Date:  2015-05-13       Impact factor: 3.452

Review 3.  Liver Trauma: Until When We Have to Delay Surgery? A Review.

Authors:  Inés Cañas García; Julio Santoyo Villalba; Domenico Iovino; Caterina Franchi; Valentina Iori; Giuseppe Pettinato; Davide Inversini; Francesco Amico; Giuseppe Ietto
Journal:  Life (Basel)       Date:  2022-05-06

4.  Comparative study of indocyanine green (ICG)-R15 and Albumin-Indocyanine Green Evaluation (ALICE) grading system in the prediction of posthepatectomy liver failure and postoperative mortality in patients with hepatic alveolar echinococcosis.

Authors:  Yuxin Liang; Zilong Zhang; Zonglin Dai; Rui Cao; Deyuan Zhong; Chunyou Lai; Yutong Yao; Tianhang Feng; Xiaolun Huang
Journal:  BMC Gastroenterol       Date:  2022-06-14       Impact factor: 2.847

5.  Living donor liver transplantation with replacement of vena cava for Echinococcus alveolaris: A case report.

Authors:  Ruslan Mamedov; Namig Novruzov; Adil Baskiran; Fahri Yetisir; Bulent Unal; Cemalettın Aydın; Nuru Bayramov; Cuneyt Kayaalp; Sezai Yilmaz
Journal:  Int J Surg Case Rep       Date:  2014-01-11

6.  Advanced alveolar echinococcosis disease associated with Budd-Chiari syndrome.

Authors:  Vural Soyer; Cengiz Ara; Faik Yaylak; Barış Sarıcı; Mustafa Ozsoy; Okay Koç; Sezai Yılmaz
Journal:  Int J Surg Case Rep       Date:  2015-01-09

7.  Surgical approaches to hepatic hydatidosis ranging from partial cystectomy to liver transplantation.

Authors:  Sanjay Goja; Sujeet Kumar Saha; Sanjay Kumar Yadav; Anisha Tiwari; Arvinder Singh Soin
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31

8.  Transhepatic-intrahepatic branches of the portal vein catheterization for ex vivo liver resection and autotransplantation: Two case reports of novel approach to perfuse the liver.

Authors:  Junjie Kong; Shu Shen; Xianwei Yang; Wentao Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

9.  Percutaneous stenting of left hepatic vein followed by Ex vivo Liver Resection and Autotransplantation in a patient with hepatic alveolar echinococcosis with Budd-Chiari syndrome.

Authors:  Yu Zhang; Ping Xie; Chong Yang; Hongji Yang; Jun Liu; Guo Zhou; Shaoping Deng; Wan Yee Lau
Journal:  Int J Surg Case Rep       Date:  2020-03-09

10.  Surgical treatment of extensive hepatic alveolar echinococcosis using a three-dimensional visualization technique combined with allograft blood vessels: A case report.

Authors:  Tiezheng Wang; Guangming Li; Zhi Fu; Daming Gao; Ning Li; Dongdong Lin
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.